Increased serum soluble corin in dyslipidemia: A cross-sectional study

Clinica Chimica Acta; International Journal of Clinical Chemistry
Xiaolei WangHao Peng

Abstract

Natriuretic peptides have been associated with dyslipidemia. As a physiological activator of natriuretic peptides, corin might also be associated with dyslipidemia. However, this association has not yet been studied in Chinese populations. Serum soluble corin and blood lipid profiles were determined for 2496 participants aged above 30y. A logistic regression model was applied to evaluate the association between serum soluble corin and dyslipidemia. Serum soluble corin was significantly increased in participants with dyslipidemia in both men (P<0.001) and women (P<0.001). After controlling for the confounding factors, OR of dyslipidemia positively increased with increasing levels of serum soluble corin in men (P for trend=0.011) and women (P for trend=0.043). Participants with a high corin level were more likely to have dyslipidemia than those with a low corin level in men (OR, 95% CI: 1.45, 1.07-1.97) and women (OR, 95% CI: 1.33, 1.04-1.70). Serum soluble corin was significantly and positively associated with dyslipidemia. Our findings suggested that serum soluble corin may be a marker or risk factor for dyslipidemia.

References

May 18, 1999·The Journal of Biological Chemistry·W YanQ Wu
Jul 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·W YanQ Wu
Mar 9, 2002·The Journal of Biological Chemistry·Faye WuQingyu Wu
Jan 8, 2005·Proceedings of the National Academy of Sciences of the United States of America·Joyce C Y ChanQingyu Wu
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Sep 16, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Aviva PelegYonathan Hasin
Jan 12, 2010·Circulation. Heart Failure·Ningzheng DongQingyu Wu
Aug 31, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ningzheng DongQingyu Wu
Feb 4, 2011·The Journal of Biological Chemistry·Jingjing JiangQingyu Wu
Jun 30, 2011·European Heart Journal·UNKNOWN European Association for Cardiovascular Prevention & RehabilitationUNKNOWN ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees
Nov 19, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ningzheng DongQingyu Wu
Feb 22, 2012·European Heart Journal Cardiovascular Imaging·Eleonora GashiItzhak Kronzon
Jan 19, 2013·Clinical Science·Chaodong FangQingyu Wu
Apr 16, 2013·Nutrients·Boudewijn KlopManuel Castro Cabezas
Sep 24, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Haibin ZhouNingzheng Dong
Nov 14, 2013·European Heart Journal. Acute Cardiovascular Care·Aviva PelegYonathan Hasin

❮ Previous
Next ❯

Citations

Feb 16, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hongmei LiHao Peng
Oct 31, 2020·Biochemical Society Transactions·Ningzheng DongQingyu Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.